SCHEMBL18726002

SCHEMBL18726002

[CH]1CCN(c2cccc(-n3ccnn3)c2)C1

nearest known ligand 0.53

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 13/20 0.53
▸ KEAP1 Q14145 1/20 0.53
▸ MAPK8 P45983 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ HCRTR1 O43613 2/20 0.36
▸ HCRTR2 O43614 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18726009 0.91 NOTUM (0.55) NOTUMKEAP1MAPK8MAPK10HCRTR1
SCHEMBL18979229 0.81 DRD2 (0.41) NOTUMHCRTR1HCRTR2
SCHEMBL14961974 0.80 NOTUM (0.75) NOTUMKEAP1
SCHEMBL29471927 0.78 MAPK8 (0.56) NOTUMKEAP1MAPK8MAPK10
SCHEMBL12099625 0.75 NOTUM (0.51) NOTUMKEAP1MAPK8MAPK10HCRTR1
SCHEMBL18979222 0.73 CYP2A6 (0.44) HCRTR1HCRTR2
SCHEMBL30731222 0.73 NOTUM (0.64) NOTUMKEAP1
SCHEMBL2627224 0.73 NOTUM (0.64) NOTUMKEAP1
SCHEMBL18979251 0.71 NOTUM (0.54) NOTUMKEAP1HCRTR1HCRTR2
SCHEMBL6399910 0.71 ADRA2C (0.55) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2632255-B1 DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES MERCK SHARP & DOHME (US) 2017-06-21 — — EP claimed
EP-2683687-B1 HETEROCYCLIC DERIVATIVES CONTAINING PRIMARY AMINO GROUPS AND DIAZENIUMDIOLATES MERCK SHARP & DOHME (US) 2017-04-19 — — EP claimed
EP-2632255-B1 DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES MERCK SHARP & DOHME (US) 2017-06-21 — — EP disclosed
EP-2683687-B1 HETEROCYCLIC DERIVATIVES CONTAINING PRIMARY AMINO GROUPS AND DIAZENIUMDIOLATES MERCK SHARP & DOHME (US) 2017-04-19 — — EP disclosed
Send feedback